HTG Molecular Diagnostics, Inc.
HTGM · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $597,802 | $354,824 | $677,473 | $1,133,253 |
| - Cash | $2,996 | $12,211 | $3,212 | $5,757 |
| + Debt | $3,981 | $4,834 | $6,053 | $9,068 |
| Enterprise Value | $598,786 | $347,447 | $680,314 | $1,136,564 |
| Revenue | $1,033 | $2,439 | $1,251 | $1,492 |
| % Growth | -57.7% | 95% | -16.1% | – |
| Gross Profit | -$117 | $408 | $580 | $477 |
| % Margin | -11.3% | 16.7% | 46.4% | 32% |
| EBITDA | -$4,828 | -$4,420 | -$4,180 | -$5,477 |
| % Margin | -467.6% | -181.2% | -334.2% | -367.2% |
| Net Income | -$5,055 | -$4,693 | -$4,516 | -$5,888 |
| % Margin | -489.6% | -192.4% | -361% | -394.8% |
| EPS Diluted | -0.023 | -0.053 | -0.049 | -0.064 |
| % Growth | 56.8% | -7.5% | 23.5% | – |
| Operating Cash Flow | -$4,364 | -$2,023 | -$4,595 | -$5,850 |
| Capital Expenditures | -$6 | $0 | -$8 | -$7 |
| Free Cash Flow | -$4,370 | -$2,023 | -$4,603 | -$5,856 |